Amesite (AMST) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Jun, 2026Executive summary
Annual meeting scheduled for July 13, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by July 12, 2026, 11:59 PM ET.
Voting matters and shareholder proposals
Election of two Class II director nominees: Ann Marie Sastry, Ph.D., and Barbie Brewer, with board recommendation to vote for both.
Ratification of Novogradac & Company LLP as independent registered public accountants for fiscal year ending June 30, 2026.
Approval of amendment to the 2018 Equity Incentive Plan to increase shares available and incentive stock options by 1,000,000 each.
Approval for issuance of up to 2,787,464 shares of common stock upon exercise of Series A-1 and Series A-2 warrants, per Nasdaq Listing Rule 5635(d).
Proxy holders may vote on other business that arises at the meeting at their discretion.
Board of directors and corporate governance
Board recommends all proposals, including director nominees and plan amendments, for shareholder approval.
Latest events from Amesite
- Annual meeting to vote on directors, auditor, equity plan amendment, and warrant exercises.AMST
Proxy filing3 Jun 2026 - Auditors flagged going concern risks; offering led by Laidlaw & Company (UK) Ltd.AMST
Registration filing26 May 2026 - Revenue increased and net loss narrowed, but going concern risks persist despite new capital.AMST
Q3 202618 May 2026 - AI healthcare firm offers 4.8M shares for resale, with viability dependent on warrant exercise proceeds.AMST
Registration filing12 May 2026 - Healthcare AI firm offers shares and warrants to fund growth amid ongoing losses and compliance risks.AMST
Registration filing20 Apr 2026 - NurseMagicâ„¢ app drives rapid revenue growth and market adoption in healthcare AI.AMST
Investor presentation6 Feb 2026 - NurseMagic's rapid adoption and scalable AI platform drive strong revenue and market growth.AMST
Investor presentation6 Feb 2026 - Revenue surged but losses persist; going concern and Nasdaq compliance risks remain.AMST
Q2 20266 Feb 2026 - Director and auditor approved; NurseMagic gains traction; strong insider investment.AMST
AGM 202510 Jan 2026